Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | GALR3 | O60755 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28489600 | 0.90 | ALDH1A1 (0.32) | TSHRALDH1A1LMNAHSD17B10 | |
| SCHEMBL8839126 | 0.84 | TSHR (0.33) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL4007769 | 0.83 | — | — | |
| Ammonia Solution, Strong SCHEMBL9998827 | 0.83 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL8839122 | 0.82 | MEN1 (0.33) | — | |
| SCHEMBL9323704 | 0.82 | MGAM (0.38) | — | |
| SCHEMBL176415 | 0.82 | LMNA (0.33) | TSHRALDH1A1LMNAMAPT | |
| SCHEMBL5186800 | 0.82 | ALOX15 (0.38) | TSHRLMNACHRM2CHRM4CHRM1 | |
| SCHEMBL3344601 | 0.82 | TSHR (0.34) | TSHRALDH1A1LMNAHSD17B10CHRM2 | |
| SCHEMBL29169354 | 0.81 | ALDH1A1 (0.31) | TSHRALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2580294-B1 | PVDF COATING COMPOSITIONS | SOLVAY SOLEXIS SPA (IT) | 2015-02-25 | — | — | EP | claimed |
| EP-2580294-A1 | PVDF COATING COMPOSITIONS | Solvay Solexis S.p.A. (IT) | 2013-04-17 | — | — | EP | claimed |
| US-20130090417-A1 | PVDF coating compositions | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2013-04-11 | — | — | US | claimed |
| WO-2011157657-A1 | PVDF COATING COMPOSITIONS | SOLVAY SOLEXIS S.P.A. (IT) | 2011-12-22 | — | — | WO | claimed |
| US-12248251-B2 | Silicon-containing resist underlayer film-forming composition including organic group having ammonium group | NISSAN CHEMICAL CORPORATION (JP) | 2025-03-11 | — | — | US | disclosed |
| EP-4458916-A1 | PHOTOCATALYTICALLY ACTIVE COATING COMPOSITION, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF | TriOptoTec GmbH (DE) | 2024-11-06 | — | — | EP | disclosed |
| US-11966164-B2 | Semiconductor device production method employing silicon-containing resist underlayer film-forming composition including organic group having ammonium group | NISSAN CHEMICAL CORPORATION (JP) | 2024-04-23 | — | — | US | disclosed |
| CN-110809739-B | Composition for forming silicon-containing resist underlayer film soluble in alkaline developer | 日产化学株式会社 | 2023-11-21 | — | — | CN | disclosed |
| US-11815815-B2 | Composition for forming silicon-containing resist underlayer film removable by wet process | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2023-11-14 | — | — | US | disclosed |
| US-20220373888-A1 | SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION INCLUDING ORGANIC GROUP HAVING AMMONIUM GROUP | NISSAN CHEMICAL CORPORATION (JP) | 2022-11-24 | — | — | US | disclosed |
| US-20220155688-A1 | ALKALINE DEVELOPER SOLUABLE SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2022-05-19 | — | — | US | disclosed |
| US-11281104-B2 | Alkaline developer soluable silicon-containing resist underlayer film-forming composition | NISSAN CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| US-6410675-B2 | Functionalized silicon compounds and methods for their synthesis and use | AFFYMETRIX, INC. | 2002-06-25 | — | — | US | disclosed |
| US-20010027187-A1 | Functionalized silicon compounds and methods for their synthesis and use | AFFYMETRIX, INC. | 2001-10-04 | — | — | US | disclosed |
| US-20010021506-A1 | Functionalized silicon compounds and methods for their synthesis and use | AFFYMETRIX, INC. | 2001-09-13 | — | — | US | disclosed |
| US-20010014453-A1 | Functionalized silicon compounds and methods for their synthesis and use | AFFYMETRIX, INC. | 2001-08-16 | — | — | US | disclosed |
| US-6262216-B1 | USED TO FORM A FUNCTIONALIZED COATING ON SUBSTRATE; ARRAY OF NUCLEIC ACIDS MAY BE COVALENTLY ATTACHED TO SUBSTRATE TO MAKE HIGH DENSITY ARRAYS TO NUCLEIC ACIDS IMMOBILIZED ON SUBSTRATE WHICH MAY BE USED IN HIGH VOLUME NUCLEIC ACID HYBRIDIZATION | AFFYMETRIX, INC. | 2001-07-17 | — | — | US | disclosed |
| WO-2000061282-A1 | POROUS SILICA SUBSTRATES FOR POLYMERS SYNTHESIS AND ASSAYS | AFFYMETRIX, INC. (US) | 2000-10-19 | — | — | WO | disclosed |
| WO-2000021967-A1 | FUNCTIONALIZED SILICON COMPOUNDS, THEIR SYNTHESIS AND USE | AFFYMETRIX, INC. (US) | 2000-04-20 | — | — | WO | disclosed |
| US-5679821-A | Process for preparing organosilicon compound | TOAGOSEI CO., LTD. (JP) | 1997-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010027187-A1 | Functionalized silicon compounds and methods for their synthesis and use | SRRT, DNMT1, SIK1 | TSHR 2887/4885ALDH1A1 1479/4885LMNA 1633/4885 |
| US-20010021506-A1 | Functionalized silicon compounds and methods for their synthesis and use | SRRT, DNMT1, SIK1 | TSHR 2887/4885ALDH1A1 1479/4885LMNA 1633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.